Meitav Dash Investments LTD Alnylam Pharmaceuticals, Inc. Transaction History

Meitav Dash Investments LTD

  • $5.67 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 13, 2019
SELL
$72.76 - $93.45 $8.12 Million - $10.4 Million
-111,610 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$62.67 - $88.33 $5,640 - $7,949
-90 Reduced 0.08%
111,610 $8.14 Million
Q3 2018

Nov 14, 2018
BUY
$87.52 - $122.67 $4.96 Million - $6.96 Million
56,700 Added 103.09%
111,700 $10.1 Million
Q2 2018

Aug 14, 2018
BUY
$88.31 - $107.8 $4.86 Million - $5.93 Million
55,000 New
55,000 $5.41 Million

Others Institutions Holding ALNY

# of Institutions
676
Shares Held
108M
Call Options Held
839K
Put Options Held
771K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.5B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Meitav Dash Investments LTD Portfolio

Follow Meitav Dash Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email